Preliminary programme
FRIDAY 15 March
14:00 – 14:55
Clinical trial meeting
15:00 – 15:05
Opening BMUC meeting
Piet Ost
RCC
Chairs: Marco Gizzi & Piet Ost
15:05 – 16:05
Systemic treatment choices in RCC: who needs what?
Christine Gennigens
Primary SBRT for RCC
Shankar Siva
16:05 – 16:30
Coffee break
Recurrent prostate cancer
Chairs: Wouter Everaerts & Sylvie Rottey & Nora Sundahl
16:30 – 18:00
Low risk versus high risk BCR: prognosis related to clinical guidance vs imaging
Alastair Lamb
Systemic therapy optimisation
Bertrand Tombal
Local therapy optimisation: metastasis-directed therapy +/- systemic treatment
Piet Ost
18:00 – 18:30
Reception
How to implement PSMA radioligand therapy in Belgium?
Chair: Karolien Goffin
18:30 – 20:00
Sequencing
Karolien Goffin
Patient selection
Carlos Artigas
How to set up an RLT program
Nadia Withofs
20:00 – 22:00
Meet-the-expert dinner
SATURDAY 16 March
09:00 – 09:05
Introduction
Piet Ost
Late breaking session on uro-oncology
Chair: Siska Van Bruwaene
09:05 – 09:45
GETUG-AFU 18 trial
Piet Ost
KEYNOTE-564 trial
Marco Gizzi
PREVENT trial
Alexander Giesen
Supportive care and setting up a trial
Chair: Thierry Roumeguère
09:45 – 10:45
How to approach a patient with lymphoedema following pelvic therapies?
Nele Devoogdt
What makes a trial appealing for a patient?
Alastair Lamb
Starting your own trial – what do you need to know?
Sanne D’Hondt
10:45 – 11:15
Coffee break
Poster winner announcement
Chair: Brieuc Sautois
11:15 – 11:30
Presentation by poster contest winner
Bladder cancer: how to optimise shared decision making?
Chairs: Marco Gizzi & Nora Sundahl & Siska Van Bruwaene
11:30 – 13:00
Early localised treatment for NMIBC
Ananya Choudhury & Evanguelos Xylinas
How to approach the elderly patient with muscle-invasive bladder cancer?
Ananya Choudhury & Evanguelos Xylinas
Do we still need chemo in 1st-line metastatic bladder cancer?
Sylvie Rottey
13:00 – 13:05
Closure
Piet Ost
13:05 – 14:00
General assembly
RIZIV/INAMI accreditation will be applied for.
Changes in programme may occur.